SCHEMBL2288475

SCHEMBL2288475

COCc1cc(O)c(C(=O)C=Cc2cc(OC)c(OC)c(OC)c2)c(OC)c1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TNFRSF1A P19438 4/20 0.61
ABCG2 Q9UNQ0 5/20 0.60
KRAS P01116 1/20 0.55
MAPT P10636 5/20 0.55
KMT2A Q03164 4/20 0.55
MEN1 O00255 3/20 0.55
CYP3A4 P08684 3/20 0.55
KDM4E B2RXH2 2/20 0.55
HPGD P15428 2/20 0.55
TDP1 Q9NUW8 2/20 0.55
APP P05067 1/20 0.55
MCL1 Q07820 1/20 0.55
ABCB1 P08183 1/20 0.55
ALDH1A1 P00352 2/20 0.54
LMNA P02545 1/20 0.54
NFKB1 P19838 1/20 0.54
DPP4 P27487 1/20 0.54
NFKB2 Q00653 1/20 0.54
RELA Q04206 1/20 0.54
KCNA3 P22001 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2288459 1.00 TNFRSF1A (0.61) TNFRSF1AABCG2KRASMAPTKMT2A
SCHEMBL12375232 0.86 MAPT (0.71) ABCG2KRASMAPTKMT2AMEN1
SCHEMBL1938375 0.85 MAPT (0.75) ABCG2MAPTKMT2AMEN1CYP3A4
SCHEMBL30384473 0.85 MAPT (0.75) ABCG2MAPTKMT2AMEN1CYP3A4
SCHEMBL1938373 0.85 MAPT (0.75) ABCG2MAPTKMT2AMEN1CYP3A4
SCHEMBL30545313 0.85 ABCG2 (0.82) ABCG2KRASMAPTKMT2AMEN1
SCHEMBL12375238 0.83 ABCG2 (0.64) TNFRSF1AABCG2KRASMAPTKMT2A
SCHEMBL19182764 0.77 KRAS (0.71) ABCG2KRASMAPTKMT2AMEN1
SCHEMBL19182765 0.77 KRAS (0.71) ABCG2KRASMAPTKMT2AMEN1
SCHEMBL10847648 0.75 ABCG2 (1.00) ABCG2MAPTKMT2AMEN1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9061984-B2 Compounds related to chalcones and benzothienopyrimidines, their synthesis, and uses to treat diseases UNIVERSITY OF LOUISVILLE RESEARCH FOUNDATION, INC. (US) 2015-06-23 US disclosed
US-20110190325-A1 COMPOUNDS, THEIR SYNTHESES, AND THIER USES THE JOHNS HOPKINS UNIVERSITY 2011-08-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110190325-A1 COMPOUNDS, THEIR SYNTHESES, AND THIER USES TERT, TYMS, NISCH TNFRSF1A 3980/4885ABCG2 1032/4885KRAS 120/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.